# FDA Inspection 859322 - Newton-Wellesley Hospital - December 02, 2013

Source: https://www.keypedia.com/records/fda_inspections/newton-wellesley-hospital/0982d287-fb8b-425e-a469-43aa66663f6b
Source feed: FDA_Inspections

> FDA Inspection 859322 for Newton-Wellesley Hospital on December 02, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 859322
- Company Name: Newton-Wellesley Hospital
- Inspection Date: 2013-12-02
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1004473 - 2017-03-13](https://www.keypedia.com/records/fda_inspections/newton-wellesley-hospital/0453be96-fbf6-47d3-9ca9-011b14e64a51)
- [FDA Inspection 966101 - 2016-03-29](https://www.keypedia.com/records/fda_inspections/newton-wellesley-hospital/66d9a837-89c6-47b6-b6a6-53f18132d502)
- [FDA Inspection 784154 - 2012-05-31](https://www.keypedia.com/records/fda_inspections/newton-wellesley-hospital/29120512-fccf-445b-9955-27acf8ace5b2)
- [FDA Inspection 676502 - 2010-08-12](https://www.keypedia.com/records/fda_inspections/newton-wellesley-hospital/63b5bcae-6b4e-4093-8fb0-cbd9f85fefec)

Company: https://www.keypedia.com/companies/newton-wellesley-hospital/e6290014-3471-482e-ab8e-61b9285e483b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d